672 antibodies rebuilt: AI-designed ‘intrabodies’ take aim at Alzheimer’s, Parkinson’s and MND from inside the cell
Researchers at the University of Essex have utilized artificial intelligence to redesign 672 antibodies into 'intrabodies' capable of functioning inside human cells. This breakthrough addresses the electrical charge barrier that previously limited antibody effectiveness to the cell membrane, potentially opening new avenues for treating neurodegenerative diseases like Alzheimer's, Parkinson's, and Motor Neurone Disease.
EGamers.io
- Entities
- Gareth Wright
- Brian Dickie
- Artificial Intelligence
- David Baker
- Alzheimer's
- Caitlin O’Shea
- Neurodegenerative Diseases
- Parkinson's Disease
- Antibody Design
- University of Essex
- Huntington's Disease
- Motor Neurone Disease
- MND Association
Original source
This article was reported and published by EGamers.io. feed.gg links to it as part of a story cluster — full text, images and rights remain with the publisher.